Tuesday, August 4, 2020
Home Medical Cannabis Partners Aurora: improving lives with high-quality cannabis products

Aurora: improving lives with high-quality cannabis products

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets through high-quality cannabis products, with sales and operations across five continents and 25 countries.

Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives with high-quality cannabis products.The company’s portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports.

Providing customers with innovative, high-quality cannabis and hemp products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

Aurora: improving lives with high-quality cannabis products

Scientific research and product development

Aurora has 40 scientific studies and publications underway or completed. This includes randomised clinical trials, observational studies, and case studies of cannabinoids on patients.

The Aurora Group of companies owns or has licensed rights to 109 patent applications or granted patents. Aurora’s current studies are focused on indications ranging from pain to refractory epilepsy and are at various stages of the clinical development pathway (Phase 1-3).

The company also supports scientific talent and leading researchers who share a mission to advance cannabis science and knowledge in modern society and medicine with cannabis-related disciplines, including biology, botany, medicine, pharmacology, neurosciences and public health and health economics.

Medical cannabis in Europe

Aurora Europe is headquartered in Berlin, Germany, with its subsidiary Aurora Deutschland, which is one of the largest authorised importers and distributors of medical cannabis in Europe.

Aurora supplies high-quality medical cannabis products to patients throughout Europe and was one of the first companies to enter the German market, with operations in effect since 2015. Aurora has a growing network of cannabis production and distribution facilities that are certified under EU Good Manufacturing Practices (GMP), enabling their products to be exported internationally.

Aurora’s Common Shares trade on the TSX and NYSE under the symbol ‘ACB’ and is a constituent of the S&P/TSX Composite Index.

For more information, please visit our website at www.auroramj.com.

RECENT PUBLICATIONS

Article in sister publication Health Europa Quarterly – Issue 8
Article in sister publication Health Europa Quarterly – Issue 11

Related Articles

Pin It on Pinterest